Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 1

Status

Recruiting 4Completed 2Not yet recruiting 1

Sponsor Class

INDUSTRY 7

Study Type

Interventional 7

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 926Neoplasms 609Breast Neoplasms 604Colorectal Neoplasms 457Neoplasm Metastasis 394Ovarian Neoplasms 328Melanoma 312Prostatic Neoplasms 311Lung Neoplasms 294Multiple Myeloma 290Recurrence 278Squamous Cell Carcinoma of Head and Neck 246Stomach Neoplasms 229Pancreatic Neoplasms 228Leukemia, Myeloid, Acute 220Triple Negative Breast Neoplasms 190Endometrial Neoplasms 190Carcinoma, Renal Cell 182Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 177Small Cell Lung Carcinoma 165Leukemia, Lymphocytic, Chronic, B-Cell 156Advanced Solid Tumors 154Lymphoma, Follicular 148Urinary Bladder Neoplasms 139Lymphoma, Large B-Cell, Diffuse 138Lymphoma 137Advanced Solid Tumor 137Uterine Cervical Neoplasms 134Head and Neck Neoplasms 134

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Tumors × 1 year × Clear all
NCT07629258 2026-06-05

GW01-200-01

Groovy Medicine (Hangzhou) Ltd.

Phase 1 Not yet recruiting
100 enrolled

Advanced Tumors

NCT06245122 2026-04-06

A Study of CS23546 in Subjects With Advanced Tumors

Chipscreen Biosciences, Ltd.

Phase 1 Recruiting
156 enrolled

Advanced Tumors

NCT07110584 2026-03-05

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

ModeX Therapeutics, An OPKO Health Company

Phase 1/2 Recruiting
235 enrolled

Advanced Tumors

NCT07205198 2026-01-08

A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Shanghai Institute Of Biological Products

Phase 1 Recruiting
160 enrolled

Advanced Tumors

NCT07179081 2025-09-17

A Study of AL58805 in Patients With Advanced Tumors

Advenchen Laboratories, LLC

Phase 1 Recruiting
40 enrolled

Advanced Tumors

NCT03444714 2025-09-15

Phase I Study of RiMO-301 With Radiation in Advanced Tumors

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
32 enrolled

Advanced Tumors

NCT05429008 2025-06-18

A Phase I Clinical Study of HMPL-A83 in Patients With Advanced Malignant Neoplasm

Hutchmed

Phase 1 Completed
40 enrolled

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡